GS Investments’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.81M | Buy |
10,837
+15
| +0.1% | +$5.35K | 2.18% | 19 |
|
|
2025
Q4 | $3.54M | Sell |
10,822
-31
| -0.3% | -$9.83K | 1.92% | 21 |
|
|
2025
Q3 | $3.06M | Buy |
10,853
+31
| +0.3% | +$8.99K | 1.52% | 25 |
|
|
2025
Q2 | $3.02M | Sell |
10,822
-122
| -1% | -$34.6K | 1.34% | 30 |
|
|
2025
Q1 | $3.41M | Sell |
10,944
-13
| -0.1% | -$3.84K | 1.61% | 25 |
|
|
2024
Q4 | $2.86M | Sell |
10,957
-426
| -4% | -$126K | 1.29% | 30 |
|
|
2024
Q3 | $3.67M | Sell |
11,383
-10
| -0.1% | -$3.27K | 1.63% | 26 |
|
|
2024
Q2 | $3.56M | Sell |
11,393
-36
| -0.3% | -$10.6K | 1.68% | 26 |
|
|
2024
Q1 | $3.25M | Buy |
11,429
+143
| +1% | +$41.8K | 1.57% | 26 |
|
|
2023
Q4 | $3.25M | Buy |
11,286
+35
| +0.3% | +$9.54K | 1.7% | 24 |
|
|
2023
Q3 | $3.02M | Sell |
11,251
-170
| -1% | -$42.4K | 1.72% | 25 |
|
|
2023
Q2 | $2.54M | Sell |
11,421
-15
| -0.1% | -$3.48K | 1.38% | 28 |
|
|
2023
Q1 | $2.76M | Hold |
11,436
| – | – | 1.6% | 24 |
|
|
2022
Q4 | $3M | Buy |
11,436
+25
| +0.2% | +$6.7K | 1.86% | 21 |
|
|
2022
Q3 | $2.57M | Sell |
11,411
-21
| -0.2% | -$5.09K | 1.7% | 22 |
|
|
2022
Q2 | $2.79M | Sell |
11,432
-30
| -0.3% | -$7.35K | 1.6% | 24 |
|
|
2022
Q1 | $2.89M | Buy |
11,462
+110
| +1% | +$25.3K | 1.63% | 22 |
|
|
2021
Q4 | $2.55M | Sell |
11,352
-90
| -0.8% | -$19K | 1.23% | 30 |
|
|
2021
Q3 | $2.43M | Buy |
+11,442
| New | +$2.63M | 1.27% | 29 |
|
|
2021
Q1 | – | Sell |
-6,290
| Closed | -$1.45M | – | 64 |
|
|
2020
Q4 | $1.45M | Buy |
+6,290
| New | +$1.45M | 1.4% | 29 |
|
|
2020
Q3 | – | Sell |
-11,700
| Closed | -$2.76M | – | 62 |
|
|
2020
Q2 | $2.76M | Sell |
11,700
-63
| -0.5% | -$14.4K | 2.2% | 17 |
|
|
2020
Q1 | $2.38M | Sell |
11,763
-129
| -1% | -$28.2K | 2.34% | 17 |
|
|
2019
Q4 | $2.2M | Sell |
11,892
-411
| -3% | -$90.6K | 1.82% | 23 |
|
|
2019
Q3 | $2.38M | Sell |
12,303
-390
| -3% | -$74.9K | 1.74% | 21 |
|
|
2019
Q2 | $2.34M | Buy |
12,693
+335
| +3% | +$60K | 1.91% | 18 |
|
|
2019
Q1 | $2.35M | Buy |
12,358
+10
| +0.1% | +$1.91K | 1.84% | 21 |
|
|
2018
Q4 | $2.4M | Buy |
12,348
+15
| +0.1% | +$2.93K | 2.02% | 16 |
|
|
2018
Q3 | $2.56M | Buy |
12,333
+171
| +1% | +$33.7K | 1.79% | 22 |
|
|
2018
Q2 | $2.24M | Sell |
12,162
-525
| -4% | -$92.9K | 1.68% | 24 |
|
|
2018
Q1 | $2.16M | Buy |
12,687
+250
| +2% | +$45.9K | 1.58% | 25 |
|
|
2017
Q4 | $2.16M | Buy |
12,437
+95
| +0.8% | +$16.8K | 1.65% | 25 |
|
|
2017
Q3 | $2.3M | Buy |
12,342
+38
| +0.3% | +$6.73K | 1.84% | 20 |
|
|
2017
Q2 | $2.12M | Buy |
+12,304
| New | +$2M | 1.59% | 20 |
|
Other funds holding AMGN
VCM
VPM
GS Investments's AMGN Position: Q1 2026 in Review
GS Investments increased its Amgen (AMGN) stake by 0.14% in Q1 2026, buying an estimated $5.35K and bringing the position to 10,837 shares worth $3.81M. The position accounts for 2.18% of the portfolio, ranked #19.
GS Investments first reported a position in AMGN in Q2 2017 and has held it in 33 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- GS Investments held 10,837 shares of Amgen worth $3.81M as of Q1 2026.
- GS Investments bought 15 Amgen shares in Q1 2026, an estimated $5.35K.
- Amgen made up 2.18% of GS Investments's portfolio in Q1 2026, its #19 holding.
- GS Investments first reported a position in Amgen in Q2 2017 and has held it in 33 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on GS Investments's 13F filing for Q1 2026, filed 6 May 2026.